As we move into 2026, InMode Ltd. (INMD) is transitioning from a specialized "radiofrequency company" to a diversified medical technology ecosystem. While the stock has faced headwinds due to high interest rates and cautious consumer sentiment in 2025, the underlying Aesthetic Devices Market research shows that InMode is doubling down on R&D to maintain its competitive moat. The...